Health Economics

High-priced medications targeting severe and previously untreatable conditions are gaining approval across South Korea, England, Australia, and Canada. These approvals come despite limited initial...

The U.S. Department of Health and Human Services (HHS) has expanded its efforts to make prescription medications more affordable for seniors. By selecting 15...

NICE, alongside international health technology assessment agencies, has unveiled a comprehensive report to enhance the use of surrogate endpoints in health economic evaluations. This...

Egyptian tertiary hospitals have successfully implemented clinical pharmacy interventions, resulting in significant cost savings and enhanced patient care over a six-year period.Clinical pharmacy services...

Infections linked to ERCP procedures are burdening Italy's healthcare system with significant financial implications. A recent study highlights the economic strain caused by multidrug-resistant...

The U.S. Department of Health and Human Services (HHS) has expanded its initiative to reduce prescription drug expenses for seniors by selecting 15 additional...

Pharmac is soliciting public input on its proposal to broaden the availability of three critical medications starting May 1, 2025. This initiative aims to...

Advanced therapy medicinal products (ATMPs) are gaining attention for their potential to revolutionize healthcare. A recent study delves into understanding what stakeholders value most...

Innovative remote monitoring technologies are proving to be a financially viable option for managing chronic depression, according to recent research. This advancement leverages mobile...

Health systems in South Korea, England, Australia, and Canada are increasingly approving high-priced medications through innovative financial arrangements, despite limited initial evidence. This trend...

Health authorities in South Korea, England, Australia, and Canada are opening doors for high-priced drugs by adopting flexible appraisal methods. These nations are prioritizing...

A recent comprehensive review highlights the superior environmental and economic benefits of reusable and reprocessed disposable instruments over new disposables in endoscopic surgery. The...

A comprehensive analysis of German statutory health insurance data from 2014 to 2019 uncovers significant insights into the prevalence, treatment patterns, and economic burden...

A comprehensive review highlights the advantages of using reusable and reprocessed disposable instruments over their new disposable counterparts in endoscopic surgery. The study meticulously...

Telehealth's expanding role in modern healthcare systems necessitates robust economic evaluations to ensure its sustainable integration and effectiveness. Economic Evaluations Fall Short of Standard Guidelines...